kalosso
gedeon richter plc - acido ibandronico - acido ibandronico
clenil compositum
promedica s.r.l. - salbutamol and beclometasone - salbutamol and beclometasone
purevax rcp felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - prodotti immunologici per felidae, - gatti - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
purevax rcpch felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - prodotti immunologici per felidae, - gatti - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
atacand plus 8/12.5 mg compresse
cps cito pharma services gmbh - candesartanum cilexetilum, hydrochlorothiazidum - compresse - tablette: candesartanum cilexetilum 8 mg, hydrochlorothiazidum 12.5 mg, carmellosum calcicum, hydroxypropylcellulosum, lactosum monohydricum 76.3 mg, magnesii stearas, maydis amylum, macrogolum 8000, pro compresso. - essenziale ipertonia - synthetika
atacand plus 16/12.5 mg compresse
cps cito pharma services gmbh - candesartanum cilexetilum, hydrochlorothiazidum - compresse - tablette: candesartanum cilexetilum 16 mg, hydrochlorothiazidum 12.5 mg, carmellosum calcicum, hydroxypropylcellulosum, lactosum monohydricum 68 mg, magnesii stearas, maydis amylum, macrogolum 8000, e 172 (flavum), e 172 (rubrum), pro compresso. - essenziale ipertonia - synthetika
atacand plus 32/12.5 mg compresse
cps cito pharma services gmbh - candesartanum cilexetilum, hydrochlorothiazidum - compresse - tablette: candesartanum cilexetilum 32 mg, hydrochlorothiazidum 12.5 mg, carmellosum calcicum, hydroxypropylcellulosum, lactosum monohydricum 148.5 mg, magnesii stearas, maydis amylum, macrogolum, e 172 (flavum), pro compresso. - essenziale ipertonia - synthetika
atacand plus 32/25 mg compresse
cps cito pharma services gmbh - candesartanum cilexetilum, hydrochlorothiazidum - compresse - tablette: candesartanum cilexetilum 32 mg, hydrochlorothiazidum 25 mg, carmellosum calcicum, hydroxypropylcellulosum, lactosum monohydricum 136 mg, magnesii stearas, maydis amylum, macrogolum, e 172 (flavum), e 172 (rubrum), pro compresso. - essenziale ipertonia - synthetika
co-candesartan sandoz 8/12.5 mg compresse
sandoz pharmaceuticals ag - candesartanum cilexetilum, hydrochlorothiazidum - compresse - candesartanum cilexetilum 8 mg, hydrochlorothiazidum 12.5 mg, lactosum monohydricum 84.08 mg, maydis amylum, povidonum k 30, carrageenanum corresp. carmellosum natricum conexum corresp. magnesii stearas, pro compresso, natrium 0.22065 mg. - essenziale ipertonia - synthetika
co-candesartan sandoz 16/12.5 mg compresse
sandoz pharmaceuticals ag - candesartanum cilexetilum, hydrochlorothiazidum - compresse - candesartanum cilexetilum 16 mg, hydrochlorothiazidum 12.5 mg, lactosum monohydricum 75.85 mg, maydis amylum, povidonum k 30, carrageenanum corresp. carmellosum natricum conexum corresp. magnesii stearas, e 172 (rubrum), e 172 (flavum), pro compresso, natrium 0.22065 mg. - essenziale ipertonia - synthetika